Skip navigation

Urology : [78] Collection home page

Browse
in this collection
Subscribe to this collection to receive daily e-mail notification of new additions RSS Feed RSS Feed RSS Feed
Collection's Items (Sorted by Submit Date in Descending order): 21 to 40 of 78
PreviewIssue DateTitle / NameAuthor(s)
May-2015Management of castration-resistant (advanced) prostate cancer (CRPC): rationale, progress and future directionsChopra, S.; Rashid, P.; Chopra, Sam; Rashid, Prem 
Apr-2005Clinical practice: review. Can we prevent prostate cancer?Chong, P.; Rashid, P.; Rashid, Prem 
Jan-2012Prostatic urethral lift: two-year results after treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasiaChin, P. T.; Bolton, D. M.; Jack, G.; Rashid, P.; Thavaseelan, J.; Yu, R. J.; Roehrborn, C. G.; Woo, H. H.; Rashid, Prem 
Oct-2016Impact of branding on public awareness of healthcare‐related governing bodies: a pilot study of the Urological Society of Australia and New Zealand brandGianduzzo, T.R.J.; Gardiner, R.A.; Rashid, Prem; Young, R.; Frydenberg, M.; Kelly, S.; Rashid, Prem 
Jul-2008Post-prostatectomy radiation therapy: consensus guidelines of the Australian and New Zealand Radiation Oncology Genito-Urinary GroupSidhom, M. A.; Kneebone, A. B.; Lehman, M.; Wiltshire, K. L.; Millar, J. L.; Mukherjee, R. K.; Shakespeare, T. P.; Tai, K. H.; Shakespeare, Thomas P. 
Sep-2023Prostate-specific membrane antigen positron emission tomography detected local failure after post-prostatectomy radiation therapy: Low rates of out-of-field recurrence validates current Australian prostate bed contouring guidelinesShakespeare, T. P.; Yap, S. Z. L.; Hsieh, M.; Tahir, A. R. M.; Armstrong, S.; Shakespeare, Thomas P.; Yap, Shaun Z.; Hsieh, Michael; Tahir, Abdul R. M. 
Mar-2016Can we avoid dose escalation for intermediate-risk prostate cancer in the setting of short-course neoadjuvant androgen deprivation?Shakespeare, T. P.; Wilcox, S. W.; Aherne, N. J.; Shakespeare, Thomas P.; Wilcox, Shea; Aherne, Noel 
May-2016Can we avoid high levels of dose escalation for high-risk prostate cancer in the setting of androgen deprivation?Shakespeare, T. P.; Wilcox, S. W.; Aherne, N. J.; Shakespeare, Thomas P.; Wilcox, Shea; Aherne, Noel 
Mar-2020Choosing between conventional and hypofractionated prostate cancer radiation therapy: Results from a study of shared decision-makingShakespeare, T. P.; Westhuyzen, J.; Fai, T. L. Y.; Aherne, N. J.; Shakespeare, Thomas P.; Westhuyzen, Justin; Aherne, Noel 
Dec-2019PSMA-PET guided dose-escalated volumetric arc therapy (VMAT) for newly diagnosed lymph node positive prostate cancer: Efficacy and toxicity outcomes at two yearsShakespeare, T. P.; Eggert, E.; Wood, M.; Westhuyzen, J.; Turnbull, K.; Rutherford, N.; Aherne, N.; Shakespeare, Thomas P.; Eggert, Elizabeth; Wood, Maree; Westhuyzen, Justin; Turnbull, Kirsty; Aherne, Noel 
Feb-2017Long-term decision regret after post-prostatectomy image-guided intensity-modulated radiotherapyShakespeare, T. P.; Chin, S.; Manuel, L.; Wen, S.; Hoffmann, M.; Wilcox, S. W.; Aherne, N. J.; Shakespeare, Thomas P.; Chin, Stephen; Hoffmann, Matthew; Wilcox, Shea; Aherne, Noel 
Oct-2016Long-Term Decision Regret After Postprostatectomy Image Guided Intensity Modulated Radiation TherapyShakespeare, T. P.; Chin, S.; Hoffmann, M.; Aherne, N.; Shakespeare, Thomas P.; Hoffmann, Matthew; Aherne, Noel 
Mar-2008Urinary incontinence-pathophysiology and management outlineSantiagu, S. K.; Arianayagam, M.; Wang, A.; Rashid, P.; Santiagu, Stanley K.; Arianayagam, Mohan; Rashid, Prem 
Oct-201624-month durability after crossover to the prostatic urethral lift from randomised, blinded shamRukstalis, D.; Rashid, P.; Bogache, W. K.; Tutrone, R. F.; Barkin, J.; Chin, P. T.; Woo, H. H.; Cantwell, A. L.; Cowan, B. E.; Bolton, D. M.; Rashid, Prem 
Dec-2013The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. StudyRoehrborn, C. G.; Gange, S. N.; Shore, N. D.; Giddens, J. L.; Bolton, D. M.; Cowan, B. E.; Brown, B. T.; McVary, K. T.; Te, A. E.; Gholami, S. S.; Rashid, P.; Moseley, W. G.; Chin, P. T.; Dowling, W. T.; Freedman, S. J.; Incze, P. F.; Coffield, K. S.; Borges, F. D.; Rukstalis, D. B.; Rashid, Prem 
Jun-2017Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. studyRoehrborn, C. G.; Barkin, J.; Gange, S. N.; Shore, N. D.; Giddens, J. L.; Bolton, D. M.; Cowan, B. E.; Cantwell, A. L.; McVary, K. T.; Te, A. E.; Gholami, S. S.; Moseley, W. G.; Chin, P. T.; Dowling, W. T.; Freedman, S. J.; Incze, P. F.; Coffield, K. S.; Herron, S.; Rashid, P.; Rukstalis, D. B.; Rashid, Prem 
2000Your prostate: questions answered.Rashid, P.; Watters, G.; Rashid, Prem; Watters, Greg 
Nov-1996Splenic rupture after extracorporeal shock wave lithotripsyRashid, P.; Steele, D.; Hunt, J.; Rashid, Prem 
2010Prostate cancer : your guide to the disease, treatment options and outcomes, 3rd EditionRashid, P.; Rashid, Prem 
Jan-2015Urology nSET 2016: fine tuning of the current programmeRashid, P.; Grills, R.; Rashid, Prem 
Collection's Items (Sorted by Submit Date in Descending order): 21 to 40 of 78